Colonic epithelial cell diversity in health and inflammatory bowel disease

The colonic epithelium facilitates host–microorganism interactions to control mucosal immunity, coordinate nutrient recycling and form a mucus barrier. Breakdown of the epithelial barrier underpins inflammatory bowel disease (IBD). However, the specific contributions of each epithelial-cell subtype...

Full description

Bibliographic Details
Main Authors: Parikh, K, Antanaviciute, AA, Fawkner-Corbett, D, Jagielowicz, M, Aulicino, A, Lagerholm, C, Davis, S, Kinchen, J, Chen, HH, Alham, N, Ashley, N, Johnson, E, Hublitz, P, Bao, L, Lukomska, J, Andev, R, Bjorklund, E, Kessler, BM, Fischer, R, Goldin, R, Koohy, H, Simmons, A
Format: Journal article
Published: Springer Nature 2019
_version_ 1797103694612791296
author Parikh, K
Antanaviciute, AA
Fawkner-Corbett, D
Jagielowicz, M
Aulicino, A
Lagerholm, C
Davis, S
Kinchen, J
Chen, HH
Alham, N
Ashley, N
Johnson, E
Hublitz, P
Bao, L
Lukomska, J
Andev, R
Bjorklund, E
Kessler, BM
Fischer, R
Goldin, R
Koohy, H
Simmons, A
author_facet Parikh, K
Antanaviciute, AA
Fawkner-Corbett, D
Jagielowicz, M
Aulicino, A
Lagerholm, C
Davis, S
Kinchen, J
Chen, HH
Alham, N
Ashley, N
Johnson, E
Hublitz, P
Bao, L
Lukomska, J
Andev, R
Bjorklund, E
Kessler, BM
Fischer, R
Goldin, R
Koohy, H
Simmons, A
author_sort Parikh, K
collection OXFORD
description The colonic epithelium facilitates host–microorganism interactions to control mucosal immunity, coordinate nutrient recycling and form a mucus barrier. Breakdown of the epithelial barrier underpins inflammatory bowel disease (IBD). However, the specific contributions of each epithelial-cell subtype to this process are unknown. Here we profile single colonic epithelial cells from patients with IBD and unaffected controls. We identify previously unknown cellular subtypes, including gradients of progenitor cells, colonocytes and goblet cells within intestinal crypts. At the top of the crypts, we find a previously unknown absorptive cell, expressing the proton channel OTOP2 and the satiety peptide uroguanylin, that senses pH and is dysregulated in inflammation and cancer. In IBD, we observe a positional remodelling of goblet cells that coincides with downregulation of WFDC2—an antiprotease molecule that we find to be expressed by goblet cells and that inhibits bacterial growth. In vivo, WFDC2 preserves the integrity of tight junctions between epithelial cells and prevents invasion by commensal bacteria and mucosal inflammation. We delineate markers and transcriptional states, identify a colonic epithelial cell and uncover fundamental determinants of barrier breakdown in IBD.
first_indexed 2024-03-07T06:23:45Z
format Journal article
id oxford-uuid:f390c44f-9acb-4d1d-a178-976173f4e9d5
institution University of Oxford
last_indexed 2024-03-07T06:23:45Z
publishDate 2019
publisher Springer Nature
record_format dspace
spelling oxford-uuid:f390c44f-9acb-4d1d-a178-976173f4e9d52022-03-27T12:13:15ZColonic epithelial cell diversity in health and inflammatory bowel diseaseJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:f390c44f-9acb-4d1d-a178-976173f4e9d5Symplectic Elements at OxfordSpringer Nature2019Parikh, KAntanaviciute, AAFawkner-Corbett, DJagielowicz, MAulicino, ALagerholm, CDavis, SKinchen, JChen, HHAlham, NAshley, NJohnson, EHublitz, PBao, LLukomska, JAndev, RBjorklund, EKessler, BMFischer, RGoldin, RKoohy, HSimmons, AThe colonic epithelium facilitates host–microorganism interactions to control mucosal immunity, coordinate nutrient recycling and form a mucus barrier. Breakdown of the epithelial barrier underpins inflammatory bowel disease (IBD). However, the specific contributions of each epithelial-cell subtype to this process are unknown. Here we profile single colonic epithelial cells from patients with IBD and unaffected controls. We identify previously unknown cellular subtypes, including gradients of progenitor cells, colonocytes and goblet cells within intestinal crypts. At the top of the crypts, we find a previously unknown absorptive cell, expressing the proton channel OTOP2 and the satiety peptide uroguanylin, that senses pH and is dysregulated in inflammation and cancer. In IBD, we observe a positional remodelling of goblet cells that coincides with downregulation of WFDC2—an antiprotease molecule that we find to be expressed by goblet cells and that inhibits bacterial growth. In vivo, WFDC2 preserves the integrity of tight junctions between epithelial cells and prevents invasion by commensal bacteria and mucosal inflammation. We delineate markers and transcriptional states, identify a colonic epithelial cell and uncover fundamental determinants of barrier breakdown in IBD.
spellingShingle Parikh, K
Antanaviciute, AA
Fawkner-Corbett, D
Jagielowicz, M
Aulicino, A
Lagerholm, C
Davis, S
Kinchen, J
Chen, HH
Alham, N
Ashley, N
Johnson, E
Hublitz, P
Bao, L
Lukomska, J
Andev, R
Bjorklund, E
Kessler, BM
Fischer, R
Goldin, R
Koohy, H
Simmons, A
Colonic epithelial cell diversity in health and inflammatory bowel disease
title Colonic epithelial cell diversity in health and inflammatory bowel disease
title_full Colonic epithelial cell diversity in health and inflammatory bowel disease
title_fullStr Colonic epithelial cell diversity in health and inflammatory bowel disease
title_full_unstemmed Colonic epithelial cell diversity in health and inflammatory bowel disease
title_short Colonic epithelial cell diversity in health and inflammatory bowel disease
title_sort colonic epithelial cell diversity in health and inflammatory bowel disease
work_keys_str_mv AT parikhk colonicepithelialcelldiversityinhealthandinflammatoryboweldisease
AT antanaviciuteaa colonicepithelialcelldiversityinhealthandinflammatoryboweldisease
AT fawknercorbettd colonicepithelialcelldiversityinhealthandinflammatoryboweldisease
AT jagielowiczm colonicepithelialcelldiversityinhealthandinflammatoryboweldisease
AT aulicinoa colonicepithelialcelldiversityinhealthandinflammatoryboweldisease
AT lagerholmc colonicepithelialcelldiversityinhealthandinflammatoryboweldisease
AT daviss colonicepithelialcelldiversityinhealthandinflammatoryboweldisease
AT kinchenj colonicepithelialcelldiversityinhealthandinflammatoryboweldisease
AT chenhh colonicepithelialcelldiversityinhealthandinflammatoryboweldisease
AT alhamn colonicepithelialcelldiversityinhealthandinflammatoryboweldisease
AT ashleyn colonicepithelialcelldiversityinhealthandinflammatoryboweldisease
AT johnsone colonicepithelialcelldiversityinhealthandinflammatoryboweldisease
AT hublitzp colonicepithelialcelldiversityinhealthandinflammatoryboweldisease
AT baol colonicepithelialcelldiversityinhealthandinflammatoryboweldisease
AT lukomskaj colonicepithelialcelldiversityinhealthandinflammatoryboweldisease
AT andevr colonicepithelialcelldiversityinhealthandinflammatoryboweldisease
AT bjorklunde colonicepithelialcelldiversityinhealthandinflammatoryboweldisease
AT kesslerbm colonicepithelialcelldiversityinhealthandinflammatoryboweldisease
AT fischerr colonicepithelialcelldiversityinhealthandinflammatoryboweldisease
AT goldinr colonicepithelialcelldiversityinhealthandinflammatoryboweldisease
AT koohyh colonicepithelialcelldiversityinhealthandinflammatoryboweldisease
AT simmonsa colonicepithelialcelldiversityinhealthandinflammatoryboweldisease